SCHEMBL3750322

SCHEMBL3750322

CCOC(=O)CN(Cc1ccccc1)C(=O)C1c2ccccc2C(=O)N1CCc1ccc(Cl)cc1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MDM2 Q00987 4/20 0.40
TP53 P04637 2/20 0.38
KCNH2 Q12809 3/20 0.38
SCN9A Q15858 3/20 0.38
SCN5A Q14524 2/20 0.38
ALDH1A1 P00352 2/20 0.38
KCNA5 P22460 2/20 0.38
LMNA P02545 1/20 0.38
NPSR1 Q6W5P4 2/20 0.37
GAA P10253 1/20 0.37
HTT P42858 1/20 0.37
P2RX7 Q99572 1/20 0.37
CYP1A2 P05177 1/20 0.37
POLB P06746 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
PIN1 Q13526 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3751140 0.88 MDM2 (0.44) MDM2TP53KCNH2SCN9ASCN5A
SCHEMBL3754163 0.85 KCNA5 (0.44) MDM2KCNH2ALDH1A1KCNA5NPSR1
SCHEMBL3762651 0.83 MDM2 (0.46) MDM2TP53KCNH2SCN9ASCN5A
SCHEMBL3745658 0.82 PRMT5 (0.47) MDM2TP53KCNH2SCN9ASCN5A
SCHEMBL3753672 0.81 MDM2 (0.48) MDM2TP53KCNH2SCN9ASCN5A
SCHEMBL3758475 0.78 MDM2 (0.46) MDM2TP53KCNH2SCN9ASCN5A
SCHEMBL3750835 0.76 MDM2 (0.57) MDM2TP53KCNH2SCN9ASCN5A
SCHEMBL3748832 0.75 KCNA5 (0.46) MDM2TP53KCNH2SCN9ASCN5A
SCHEMBL3756012 0.74 SCN9A (0.51) MDM2TP53KCNH2SCN9ASCN5A
SCHEMBL3753733 0.72 ALDH1A1 (0.62) MDM2TP53KCNH2SCN9ASCN5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100298392-A1 Isoindoline Derivatives For The Treatment Of Arrhythmias ASTRAZENECA AB (SE) 2010-11-25 US claimed
US-20080015237-A1 NEW COMPOUNDS I/418 ASTRAZENECA AB (SE) 2008-01-17 US claimed
US-20100298392-A1 Isoindoline Derivatives For The Treatment Of Arrhythmias ASTRAZENECA AB (SE) 2010-11-25 US disclosed
US-20080015237-A1 NEW COMPOUNDS I/418 ASTRAZENECA AB (SE) 2008-01-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080015237-A1 NEW COMPOUNDS I/418 KCNH1, KCNH2, KCNH3 MDM2 3686/4885TP53 3912/4885KCNH2 2/4885
US-20100298392-A1 Isoindoline Derivatives For The Treatment Of Arrhythmias KCNH1, KCNH2, KCNQ2 MDM2 3351/4885TP53 3602/4885KCNH2 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.